New Capital Management LP Compass Therapeutics, Inc. Transaction History

New Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$1.4 - $1.98 $4,356 - $6,161	-3,112 Reduced 12.84%	21,131 $32,000
Q2 2022 Jul 08, 2022	BUY	$1.43 - $3.1 $34,667 - $75,153	24,243 New	24,243 $69,000
Q1 2022 Apr 08, 2022	SELL	$1.25 - $3.5 $30,303 - $84,850	-24,243 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$2.88 - $3.98 $69,819 - $96,487	24,243 New	24,243 $77,000

91.9M

Ticker CMPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 101,285,000
Market Cap $139M
Description
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...

Get notified when there are updates to the investment portfolio of New Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on New Capital Management LP with notifications on news.